Female Health ROA 2006-2018 | VERU

Current and historical return on assets (ROA) values for Female Health (VERU) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Female Health ROA for the three months ending December 31, 2018 was -41.10%.
Female Health ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2018-12-31 $-0.02B $0.05B -41.71%
2018-09-30 $-0.02B $0.05B -45.71%
2018-06-30 $-0.02B $0.05B -38.71%
2018-03-31 $-0.01B $0.06B -25.34%
2017-12-31 $-0.01B $0.05B -21.82%
2017-09-30 $-0.01B $0.06B -15.65%
2017-06-30 $-0.01B $0.06B -11.21%
2017-03-31 $-0.00B $0.06B -8.08%
2016-12-31 $-0.00B $0.06B -4.42%
2016-09-30 $0.00B $0.04B 0.00%
2016-06-30 $0.00B $0.04B 7.64%
2016-03-31 $0.00B $0.04B 7.84%
2015-12-31 $0.01B $0.04B 13.42%
2015-09-30 $0.01B $0.04B 13.99%
2015-06-30 $0.00B $0.04B 8.70%
2015-03-31 $0.00B $0.04B 8.96%
2014-12-31 $0.00B $0.03B 3.05%
2014-09-30 $0.00B $0.03B 3.01%
2014-06-30 $0.01B $0.03B 26.47%
2014-03-31 $0.01B $0.03B 26.67%
2013-12-31 $0.01B $0.04B 35.56%
2013-09-30 $0.02B $0.04B 46.15%
2013-06-30 $0.02B $0.03B 51.20%
2013-03-31 $0.02B $0.03B 61.02%
2012-12-31 $0.02B $0.03B 62.96%
2012-09-30 $0.02B $0.03B 64.65%
2012-06-30 $0.01B $0.03B 59.09%
2012-03-31 $0.01B $0.02B 51.28%
2011-12-31 $0.01B $0.02B 45.07%
2011-09-30 $0.01B $0.02B 29.85%
2011-06-30 $0.01B $0.02B 36.36%
2011-03-31 $0.01B $0.02B 36.92%
2010-12-31 $0.01B $0.02B 49.23%
2010-09-30 $0.01B $0.02B 44.44%
2010-06-30 $0.00B $0.01B 18.75%
2010-03-31 $0.00B $0.02B 24.62%
2009-12-31 $0.00B $0.02B 25.81%
2009-09-30 $0.01B $0.02B 47.46%
2009-06-30 $0.01B $0.02B 51.85%
2009-03-31 $0.01B $0.01B 53.85%
2008-12-31 $0.01B $0.01B 46.15%
2008-09-30 $0.01B $0.01B 37.74%
2008-06-30 $0.00B $0.01B 32.00%
2008-03-31 $0.00B $0.01B 26.09%
2007-12-31 $0.00B $0.01B 19.05%
2007-09-30 $0.00B $0.01B 10.81%
2007-06-30 $0.00B $0.01B 0.00%
2007-03-31 $0.00B $0.01B 0.00%
2006-12-31 $0.00B $0.01B 0.00%
2006-09-30 $0.00B $0.01B 0.00%
2006-06-30 $0.00B $0.01B 0.00%
2006-03-31 $0.00B $0.01B 0.00%
2005-12-31 $0.00B $0.01B 0.00%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.084B $0.016B
Veru Inc. engages in the development, manufacture and marketing of consumer health care products. It focuses on producing FC2 female condom which provides dual protection against unintended pregnancy and sexually transmitted infections. Veru Inc., formerly known as The Female Health Company, is headquartered in Miami, FL.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $132.673B 26.23
Medtronic (MDT) Ireland $124.635B 18.20
Stryker (SYK) United States $69.927B 25.67
Boston Scientific (BSX) United States $55.591B 27.10
Baxter (BAX) United States $39.448B 24.31
Zimmer Biomet Holdings (ZBH) United States $25.289B 16.23
Smith & Nephew SNATS (SNN) United Kingdom $16.755B 0.00
ResMed (RMD) United States $14.297B 27.11
Canopy Growth (CGC) Canada $10.742B 0.00
Bio-Rad Laboratories (BIO) United States $8.172B 52.25
Aurora Cannabis (ACB) Canada $7.060B 50.50
Hill-Rom Holdings (HRC) United States $6.958B 21.52
Perrigo (PRGO) Ireland $6.649B 10.09
ICU Medical (ICUI) United States $5.184B 28.88
Insulet (PODD) United States $5.071B 0.00
Haemonetics (HAE) United States $4.540B 40.28
GW Pharmaceuticals (GWPH) United Kingdom $4.400B 0.00
Agios Pharmaceuticals (AGIO) United States $3.380B 0.00
Hutchison China MediTech (HCM) China $3.329B 0.00
Neogen (NEOG) United States $3.267B 50.18
NuVasive (NUVA) United States $2.850B 24.96
Quidel (QDEL) United States $2.761B 24.91
National Vision Holdings (EYE) United States $2.637B 51.01
Aphria (APHA) $2.539B 112.78
NxStage Medical (NXTM) United States $2.000B 0.00
AtriCure (ATRC) United States $1.274B 0.00
HEXO (HEXO) $1.242B 0.00
Cardiovascular Systems (CSII) United States $1.240B 890.25
Phibro Animal Health (PAHC) United States $1.220B 17.53
VAREX IMAGING (VREX) United States $1.212B 23.73
MacroGenics (MGNX) United States $0.939B 0.00
Cerus (CERS) United States $0.904B 0.00
PetIQ (PETQ) United States $0.867B 22.47
Lantheus Holdings (LNTH) United States $0.847B 22.95
Surmodics (SRDX) United States $0.785B 114.20
Meridian Bioscience (VIVO) United States $0.733B 21.85
NanoString Technologies (NSTG) United States $0.721B 0.00
OraSure Technologies (OSUR) United States $0.720B 31.76
Omeros (OMER) United States $0.719B 0.00
Evolus (EOLS) United States $0.705B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.647B 20.75
LeMaitre Vascular (LMAT) United States $0.603B 28.76
Quanterix (QTRX) United States $0.518B 0.00
Insys Therapeutics (INSY) United States $0.426B 0.00
Owens & Minor (OMI) United States $0.408B 5.65
TG Therapeutics (TGTX) United States $0.398B 0.00
Utah Medical Products (UTMD) United States $0.339B 21.99
BioLife Solutions (BLFS) United States $0.329B 445.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.294B 0.00
Vapotherm (VAPO) United States $0.288B 0.00
Bovie Medical (APYX) United States $0.282B 0.00
Rockwell Medical (RMTI) United States $0.262B 0.00
Cytosorbents (CTSO) United States $0.256B 0.00
Zynex (ZYXI) United States $0.174B 16.84
Fonar (FONR) United States $0.144B 7.70
Surface Oncology (SURF) United States $0.140B 0.00
Chembio Diagnostics (CEMI) United States $0.112B 0.00
Chimerix (CMRX) United States $0.100B 0.00
United-Guardian (UG) United States $0.090B 18.77
InfuSystems Holdings (INFU) United States $0.078B 0.00
CAS Medical Systems (CASM) United States $0.070B 0.00
Trinity Biotech (TRIB) Ireland $0.066B 18.20
Conatus Pharmaceuticals (CNAT) United States $0.057B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.056B 0.00
ImmuCell (ICCC) United States $0.038B 0.00
Neurotrope (NTRP) United States $0.034B 0.00
Senestech (SNES) United States $0.021B 0.00
Myomo (MYO) United States $0.016B 0.00
Akers Biosciences Inc (AKER) United States $0.014B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.014B 0.00
Capricor Therapeutics (CAPR) United States $0.013B 0.00
Valeritas Holdings (VLRX) United States $0.010B 0.00
Cellectar Biosciences (CLRB) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.008B 14.14